News
Electronics and pharma sectors dominated PLI scheme disbursements in FY25, receiving 70% of the total Rs 10,114 crore. Strong ...
Photoactivated ketones show strong potential as hydrogen atom transfer photocatalysts, enabling the activation of carboxylic ...
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have ...
(Reuters) -Varda Space Industries said on Thursday it has raised $187 million in a funding round led by venture capital firms ...
Medical marijuana programs across Europe vary greatly but most only allow cannabis products to be dispensed through ...
The U.S. House committee is raising concerns over GenScript's ties to China. Discover the latest developments in ...
Globally, $105.3 billion worth of pharmaceuticals and biotech M&A deals have been inked so far in 2025, according to data ...
Australia is “urgently seeking more detail” on U.S. President Donald Trump’s threat to raise tariffs up to 200% on ...
In spite of this underperformance, the clinical-stage TechBio firm continues to attract interest for its innovative approach ...
"No More Tears," by Gardiner Harris, is a scathing expose of Johnson & Johnson and its many missteps and transgressions.
Treating the neurodegenerative disease in its earlier stages is key to slowing cognitive decline. A new study offers hope for the future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results